Cite
HARVARD Citation
Berweck, S. et al. (n.d.). Efficacy and safety of incobotulinumtoxin/A in the treatment of 2- to 5-year-old children with chronic sialorrhea associated with neurological disorders and/or intellectual disability. Toxicon. pp. S8-S9. [Online].